Liz Loehrer

I joined the Schmidt group at the NKI in January 2024 as a postdoctoral researcher for the Hebon consortium, a national study of families with high risk for breast and ovarian cancer. Within the study, I contribute to the collection, credentialling and integration of imaging markers, genetic information, and personal factors with the ultimate goal to help personalize cancer risk prediction, surveillance, and clinical follow-up for women in families with hereditably high risk for breast cancer.